Eagle’s Eye View: What are the cardiovascular...

In this week's View, Dr. Eagle looks at a collaborative analysis of three randomized trials that investigated inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy. He then covers the 2023 ACC Expert Consensus Decision Pathway ...  Show more

In this week’s View, Dr. Deepak Bhatt sits in for Dr. Eagle and discusses heart failure following anti-inflammatory medications in patients with type 2 diabetes mellitus, then looks at the results of the ARCHITECT Study concerning alirocumab and coronary atherosclerosis in asympt ...  Show more

The ORBITA sham-control PCI study, Watchman, revascularization in cardiogenic shock, Absorb BVS, quality-of-life outcomes after PCI or bypass, and chronic total occlusion PCI are discussed in this week's podcast. 

Two trials of statin therapy in acute coronary syndrome. See https://cardiologytrials.substack.com/ for more details. Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe 

In this episode, Editor-in-Chief Harlan Krumholz explores the evolving landscape of cardiovascular medicine, beginning with a call for responsible stewardship of artificial intelligence. Highlights include a major registry study on percutaneous aspiration for right-sided endocard ...  Show more

A new trial assessed whether balloon angioplasty plus aggressive medical management was superior to aggressive medical management alone for patients with symptomatic intracranial atherosclerotic stenosis. Author Zhongrong Miao, MD, PhD, from Beijing Tiantan Hospital, discusses ...